4.7 Review

Challenges, Solutions, and Quality Metrics of Personal Genome Assembly in Advancing Precision Medicine

Journal

PHARMACEUTICS
Volume 8, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/pharmaceutics8020015

Keywords

genome; sequencing; assembly; personal genome; quality metrics

Funding

  1. National Center for Toxicological Research (NCTR) of the U.S. Food and Drug Administration through the Oak Ridge Institute for Science and Education (ORISE)

Ask authors/readers for more resources

Even though each of us shares more than 99% of the DNA sequences in our genome, there are millions of sequence codes or structure in small regions that differ between individuals, giving us different characteristics of appearance or responsiveness to medical treatments. Currently, genetic variants in diseased tissues, such as tumors, are uncovered by exploring the differences between the reference genome and the sequences detected in the diseased tissue. However, the public reference genome was derived with the DNA from multiple individuals. As a result of this, the reference genome is incomplete and may misrepresent the sequence variants of the general population. The more reliable solution is to compare sequences of diseased tissue with its own genome sequence derived from tissue in a normal state. As the price to sequence the human genome has dropped dramatically to around $1000, it shows a promising future of documenting the personal genome for every individual. However, de novo assembly of individual genomes at an affordable cost is still challenging. Thus, till now, only a few human genomes have been fully assembled. In this review, we introduce the history of human genome sequencing and the evolution of sequencing platforms, from Sanger sequencing to emerging third generation sequencing technologies. We present the currently available de novo assembly and post-assembly software packages for human genome assembly and their requirements for computational infrastructures. We recommend that a combined hybrid assembly with long and short reads would be a promising way to generate good quality human genome assemblies and specify parameters for the quality assessment of assembly outcomes. We provide a perspective view of the benefit of using personal genomes as references and suggestions for obtaining a quality personal genome. Finally, we discuss the usage of the personal genome in aiding vaccine design and development, monitoring host immune-response, tailoring drug therapy and detecting tumors. We believe the precision medicine would largely benefit from bioinformatics solutions, particularly for personal genome assembly.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Toxicology

Identification of Translational microRNA Biomarker Candidates for Ketoconazole-Induced Liver Injury Using Next-Generation Sequencing

Dongying Li, Bridgett Knox, Binsheng Gong, Si Chen, Lei Guo, Zhichao Liu, Weida Tong, Baitang Ning

Summary: The study focused on investigating miRNA biomarkers for KCZ-induced liver injury by integrating in vivo, in vitro, and bioinformatics analyses. Significant dysregulation of miR-34a-5p, miR-331-3p, and miR-15b-3p was associated with cytoplasmic vacuolization in rat livers with KCZ-induced injury. These miRNAs, along with miR-676, showed evolutionary conservation and could potentially serve as translational biomarkers for early detection of liver injury.

TOXICOLOGICAL SCIENCES (2021)

Review Pharmacology & Pharmacy

Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics

Li Zeng, Dongying Li, Weida Tong, Tieliu Shi, Baitang Ning

Summary: The study proposes a method to monitor and predict the impact of viral mutations on drug safety and efficacy, emphasizing the importance of the three main viral proteins and suggesting the establishment of an interactive database.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Chemistry, Medicinal

Impact of Sequencing Depth and Library Preparation on Toxicological Interpretation of RNA-Seq Data in a Three-Sample Scenario

Dongying Li, Binsheng Gong, Joshua Xu, Baitang Ning, Weida Tong

Summary: This study investigated the impact of sequencing depth and library preparation on toxicological interpretation in RNA-seq using three samples. Results showed that a minimum of 20 million reads was sufficient to reveal key toxicity pathways, and identification of differentially expressed genes was positively associated with sequencing depth. Overall, RNA-seq had higher statistical power and overlap ratio in toxicological insights compared to TempO-seq and microarray.

CHEMICAL RESEARCH IN TOXICOLOGY (2021)

Review Pharmacology & Pharmacy

Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges

Kiara Fairman, Miao Li, Baitang Ning, Annie Lumen

Summary: PBPK modeling is a powerful tool with potential applications in the development of RNAi therapeutics, a class of drugs with unique pharmacokinetic properties. While there is active research in this area, there are still challenges to fully evaluating the utility of PBPK models for RNAi therapeutics. The current computational modeling approaches can support efficient development and approval of RNAi therapeutics, but further exploration and standardization are needed to optimize their use.

BIOCHEMICAL PHARMACOLOGY (2021)

Editorial Material Pharmacology & Pharmacy

RNA therapeutics: From biochemical pharmacology to technology development and clinical applications Preface

Baitang Ning, Ai-Ming Yu

BIOCHEMICAL PHARMACOLOGY (2021)

Article Engineering, Environmental

Developing QSAR Models with Defined Applicability Domains on PPARγ Binding Affinity Using Large Data Sets and Machine Learning Algorithms

Zhongyu Wang, Jingwen Chen, Huixiao Hong

Summary: This study developed 30 QSAR models based on PPAR gamma binding affinity data, using molecular fingerprints, two-dimensional descriptors, and five machine learning algorithms. Local discontinuity scores were positively correlated with prediction errors of the models, and innovative ADs outperformed traditional ones. The curated data sets and models can be used to evaluate adverse effects of chemicals.

ENVIRONMENTAL SCIENCE & TECHNOLOGY (2021)

Article Virology

Identification of Epidemiological Traits by Analysis of SARS-CoV-2 Sequences

Bohu Pan, Zuowei Ji, Sugunadevi Sakkiah, Wenjing Guo, Jie Liu, Tucker A. Patterson, Huixiao Hong

Summary: The transmission of SARS-CoV-2 is primarily through person-to-person contact, and phylogenetic analysis revealed a co-expansion tendency of the virus among neighboring countries. Pairwise sequence similarity analysis showed that SARS-CoV-2 is transmitted locally and evolves during transmission, with no significant differences in genomes grouped by host age or sex.

VIRUSES-BASEL (2021)

Article Biochemistry & Molecular Biology

Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations

Sugunadevi Sakkiah, Chandrabose Selvaraj, Wenjing Guo, Jie Liu, Weigong Ge, Tucker A. Patterson, Huixiao Hong

Summary: ERalpha is a ligand-dependent transcriptional factor, and this study used molecular docking, molecular dynamics simulations, and quantum mechanical calculations to elucidate the dynamic binding patterns of agonists and antagonists in ER alpha. The results showed that OHT binds ER alpha more tightly in the antagonist conformer, while E2 prefers the agonist conformer, which may have implications for drug development and risk assessment related to ER-mediated responses.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Medicinal

Predictive Models to Identify Small Molecule Activators and Inhibitors of Opioid Receptors

Srilatha Sakamuru, Jinghua Zhao, Menghang Xia, Huixiao Hong, Anton Simeonov, Iosif Vaisman, Ruili Huang

Summary: Novel computational models were developed to predict the activity of opioid receptors based on chemical structures, successfully identifying new active compounds. Experimental validation showed that the best performing model, using the random forest classifier, achieved hit rates ranging from 2.3% to 15.8%, enriching hit rates by >= 2-fold compared to the original assay.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Article Chemistry, Multidisciplinary

Deep Learning Models for Predicting Gas Adsorption Capacity of Nanomaterials

Wenjing Guo, Jie Liu, Fan Dong, Ru Chen, Jayanti Das, Weigong Ge, Xiaoming Xu, Huixiao Hong

Summary: The study developed models for predicting the gas adsorption capacities of MOFs using two deep learning algorithms (MLP and LSTM) and evaluated their performance. The results showed that these deep learning models are more accurate than traditional machine learning algorithms, especially for predicting gas adsorption capacities at low pressures.

NANOMATERIALS (2022)

Article Chemistry, Medicinal

TransOrGAN: An Artificial Intelligence Mapping of Rat Transcriptomic Profiles between Organs, Ages, and Sexes

Ting Li, Ruth Roberts, Zhichao Liu, Weida Tong

Summary: Animal studies are crucial for drug evaluation to ensure safety. We have proposed a novel framework called TransOrGAN that uses a generative adversarial network to map gene expression profiles across different organ systems, sexes, and ages in rodents. Our proof-of-concept study demonstrates that TransOrGAN can accurately infer transcriptomic profiles between organs, sexes, and ages, providing an opportunity to reduce animal usage and assess overall toxicity.

CHEMICAL RESEARCH IN TOXICOLOGY (2023)

Review Biochemistry & Molecular Biology

Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody

Myeongsang Lee, Marian Major, Huixiao Hong

Summary: Since November 2021, the Omicron variant of SARS-CoV-2 has been the dominant cause of COVID-19 and has shown increased transmission and infection rates. The Omicron spike protein has unique properties and can evade neutralizing antibodies due to mutations in the receptor binding domain. This review analyzes the structural changes of the Omicron spike protein in the presence and absence of ACE2 and antibodies, which can contribute to the development of effective vaccines against the Omicron variant.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

A Weakly Supervised Deep Learning Framework for Whole Slide Classification to Facilitate Digital Pathology in Animal Study

Nicole Bussola, Joshua Xu, Leihong Wu, Lorenzo Gorini, Yifan Zhang, Cesare Furlanello, Weida Tong

Summary: The pathology of animal studies is important for toxicity evaluations and regulatory assessments. However, manual examination of slides by pathologists is time-consuming and has variability issues. To address this, researchers developed PathologAI, a weakly supervised approach for classifying rat images without explicit lesion annotation. PathologAI can provide an inexpensive and rapid screening tool for preclinical applications and toxicological studies.

CHEMICAL RESEARCH IN TOXICOLOGY (2023)

Article Chemistry, Medicinal

Classifying Free Texts Into Predefined Sections Using AI in Regulatory Documents: A Case Study with Drug Labeling Documents

Magnus Gray, Joshua Xu, Weida Tong, Leihong Wu

Summary: In order to improve the efficiency of document organization and review in regulatory agencies, researchers used an artificial intelligence-based natural language processing method (BERT) to automatically classify free-text information into standardized sections, supporting a holistic review of drug safety and efficacy.

CHEMICAL RESEARCH IN TOXICOLOGY (2023)

Review Pharmacology & Pharmacy

Measurement and Mitigation of Bias in Artificial Intelligence: A Narrative Literature Review for Regulatory Science

Magnus Gray, Ravi Samala, Qi Liu, Denny Skiles, Joshua Xu, Weida Tong, Leihong Wu

Summary: This literature review examines the current state of research on AI bias, including its sources, as well as methods for measuring, benchmarking, and mitigating it. The paper specifically focuses on biases and methods of mitigation relevant to the healthcare field, and offers a perspective on bias measurement and mitigation in regulatory science decision making.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

No Data Available